Tuesday's session delivered a split verdict on Wall Street, with the major averages pulling in different directions and offering little clarity on the market's near-term conviction. The Dow Jones Industrial Average eked out a modest gain of +0.16%, closing at 49,475.33, while the broader S&P 500 slipped -0.15% to 7,389.18. The tech-heavy Nasdaq bore the brunt of the selling, falling -0.85% to 25,672.81.
Small-caps fared even worse, with the Russell 2000 dropping -0.97% to 2,814.4 — a signal that risk appetite among investors is quietly deteriorating beneath the surface of the large-cap indices. When small-caps underperform meaningfully alongside Nasdaq weakness, it often suggests a cautious repositioning rather than a broad bullish tape.
Gold continued to shine as a haven, with the precious metal quoted at $4,727.6, reflecting persistent demand for hard assets in an uncertain macro environment. The divergence between a resilient Dow and a struggling Nasdaq underscores a market rotating toward defensive and value-oriented names.
UnitedHealth Group was the standout story of the day, surging +3.11% to $396.39 and providing meaningful upside support to the Dow. Tesla, meanwhile, was the session's most notable drag, shedding -2.60% to $433.45 as growth stocks remained out of favor.